当前位置:首页 - 行情中心 - 蓝帆医疗(002382) - 财务分析 - 现金流量表

蓝帆医疗

(002382)

  

流通市值:67.52亿  总市值:68.19亿
流通股本:9.97亿   总股本:10.07亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,538,261,374.826,173,072,915.834,526,716,602.873,042,889,817.75
  收到的税费返还100,369,617.61350,549,878.5283,408,378.94207,321,050.31
  收到其他与经营活动有关的现金104,290,439.2164,552,706.5686,569,128.6478,786,883.85
  经营活动现金流入小计1,742,921,431.636,688,175,500.894,896,694,110.453,328,997,751.91
  购买商品、接受劳务支付的现金1,114,218,035.954,417,873,541.993,391,004,307.922,145,077,452
  支付给职工以及为职工支付的现金357,270,918.951,181,543,186.56881,728,126.6608,256,150.59
  支付的各项税费93,559,830.27187,921,415.76152,987,217.72100,447,848.67
  支付其他与经营活动有关的现金105,636,116.03443,114,109243,698,283.31140,063,546.1
  经营活动现金流出小计1,670,684,901.26,230,452,253.314,669,417,935.552,993,844,997.36
  经营活动产生的现金流量净额72,236,530.43457,723,247.58227,276,174.9335,152,754.55
二、投资活动产生的现金流量:
  收回投资收到的现金1,742,562,676.9795,745,438.861,592,448,285.63686,234,374.23
  取得投资收益收到的现金6,892,574.0322,184,723.9949,320,646.924,575,864.72
  处置固定资产、无形资产和其他长期资产收回的现金净额2,660,030.132,599,328.99447,010.08438,570.78
  投资活动现金流入小计1,752,115,281.13120,529,491.841,642,215,942.63691,248,809.73
  购建固定资产、无形资产和其他长期资产支付的现金131,116,641.08553,011,903.89519,388,942.7412,870,328.96
  投资支付的现金1,321,721,945.16603,130,439.161,985,810,000945,000,000
  取得子公司及其他营业单位支付的现金-228,758,904.2--
  投资活动现金流出小计1,452,838,586.241,384,901,247.252,505,198,942.71,357,870,328.96
  投资活动产生的现金流量净额299,276,694.89-1,264,371,755.41-862,983,000.07-666,621,519.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金0710,360,000220,000,000220,000,000
  其中:子公司吸收少数股东投资收到的现金0710,360,000220,000,000220,000,000
  取得借款收到的现金47,071,016.52878,001,048.62773,506,579.03514,221,697.47
  收到其他与筹资活动有关的现金2,632,334.44234,380,0004,970,232.246,970,232.24
  筹资活动现金流入小计49,703,350.961,822,741,048.62998,476,811.27741,191,929.71
  偿还债务支付的现金517,167,902.76882,842,107.74837,284,307.44467,128,251.68
  分配股利、利润或偿付利息支付的现金14,352,407.97168,383,837.6284,137,864.4763,750,513.2
  支付其他与筹资活动有关的现金3,593,026.37233,195,819.2314,136,756.6811,397,248.85
  筹资活动现金流出小计535,113,337.11,284,421,764.59935,558,928.59542,276,013.73
  筹资活动产生的现金流量净额-485,409,986.14538,319,284.0362,917,882.68198,915,915.98
四、汇率变动对现金及现金等价物的影响-19,411,755.37-2,604,335.3316,287,696.0519,833,790.97
五、现金及现金等价物净增加额-133,308,516.19-270,933,559.13-556,501,246.44-112,719,057.73
  加:期初现金及现金等价物余额1,623,046,588.471,893,980,147.61,822,024,927.481,822,024,927.48
  期末现金及现金等价物余额1,489,738,072.281,623,046,588.471,265,523,681.041,709,305,869.75
补充资料:
  净利润--798,411,318.3--142,818,987.68
  资产减值准备-198,251,820.61-65,585,393.08
  固定资产和投资性房地产折旧-484,312,280.94-233,931,678.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-484,312,280.94-233,931,678.19
  无形资产摊销-71,077,992.01-33,573,558.39
  长期待摊费用摊销-16,027,709.32-7,716,646.31
  处置固定资产、无形资产和其他长期资产的损失-1,649,674.87-372,425.04
  固定资产报废损失-71,696,464.54--1,286.91
  公允价值变动损失--497,722.83--6,523,442.42
  财务费用-233,497,346.82-137,452,699.13
  投资损失--16,798,003.93--5,592,656.84
  递延所得税--75,086,030.61--85,570,927.05
  其中:递延所得税资产减少--40,594,945.33--56,615,916.94
    递延所得税负债增加--34,491,085.28--28,955,010.11
  存货的减少-10,217,402.93--6,113,859.59
  经营性应收项目的减少-194,147,513.02-71,189,910.67
  经营性应付项目的增加-49,140,302.35-23,794,466.94
  其他-1,369,654.21-1,144,208.44
  债务转为资本-106,545.52-11,100
  一年内到期的可转换公司债券---1,573,602,525.93
  现金的期末余额-1,623,046,588.47-1,709,305,869.75
  减:现金的期初余额-1,893,980,147.6-1,822,024,927.48
  现金及现金等价物的净增加额--270,933,559.13--112,719,057.73
公告日期2026-04-292026-04-292025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑